56 Clinical Trials for: SEARCH[STUDY] GSK2118436, Page 1 of 3

Hide Studies Not Seeking New Volunteers

18

Dabrafenib and Lapatinib Ditosylate in Treating Patients With Refractory Thyroid Cancer That Cannot Be Removed by Surgery

Condition(s): Anaplastic Thyroid Cancer; Insular Thyroid Cancer; Recurrent Thyroid Cancer; Stage IVA Follicular Thyroid Cancer; Stage IVA Papillary Thyroid Cancer; Stage IVB Follicular Thyroid Cancer; Stage IVB Papillary Thyroid Cancer; Stage IVC Follicular Thyroid Cancer; Stage IVC Papillary Thyroid Cancer; Thyroid Gland Medullary Carcinoma; Thyroid Gland Nonmedullary Carcinoma Last Updated: September 16, 2014Recruiting